Piperacillin-tazobactam as alternative to carbapenems for ICU patients.
Identifieur interne : 000605 ( Main/Exploration ); précédent : 000604; suivant : 000606Piperacillin-tazobactam as alternative to carbapenems for ICU patients.
Auteurs : Benoit Pilmis [France] ; Vincent Jullien [France] ; Alexis Tabah [Australie] ; Jean-Ralph Zahar [France] ; Christian Brun-Buisson [France]Source :
- Annals of intensive care [ 2110-5820 ] ; 2017.
Abstract
Several studies suggest that alternatives to carbapenems, and particulary beta-lactam/beta-lactamase inhibitor combinations, can be used for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-related infections in non-ICU patients. Little is known concerning ICU patients in whom achieving the desired plasmatic pharmacokinetic/pharmacodynamic (PK/PD) target may be difficult. Also, in vitro susceptibility to beta-lactamase inhibitors might not translate into clinical efficacy. We reviewed the recent clinical studies examining the use of BL/BLI as alternatives to carbapenems for therapy of bloodstream infection, PK/PD data and discuss potential ecological benefit from avoiding the use of carbapenems. With the lack of prospective randomized studies, treating ICU patients with ESBL-PE-related infections using piperacillin-tazobactam should be done with caution. Current data suggest that BL/BLI empirical use should be avoided for therapy of ESBL-PE-related infection. Also, definitive therapy should be reserved to patients in clinical stable condition, after microbial documentation and results of susceptibility tests. Optimization of administration and higher dosage should be used in order to reach pharmacological targets.
DOI: 10.1186/s13613-017-0334-x
PubMed: 29127502
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000135
- to stream PubMed, to step Curation: 000135
- to stream PubMed, to step Checkpoint: 000135
- to stream Ncbi, to step Merge: 005199
- to stream Ncbi, to step Curation: 005199
- to stream Ncbi, to step Checkpoint: 005199
- to stream Main, to step Merge: 000600
- to stream Main, to step Curation: 000605
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Piperacillin-tazobactam as alternative to carbapenems for ICU patients.</title><author><name sortKey="Pilmis, Benoit" sort="Pilmis, Benoit" uniqKey="Pilmis B" first="Benoit" last="Pilmis">Benoit Pilmis</name><affiliation wicri:level="4"><nlm:affiliation>Service de maladies infectieuses et tropicales, Hôpital Necker Enfants malades, Service de maladies infectieuses et tropicales, Université Paris Descartes, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de maladies infectieuses et tropicales, Hôpital Necker Enfants malades, Service de maladies infectieuses et tropicales, Université Paris Descartes, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Jullien, Vincent" sort="Jullien, Vincent" uniqKey="Jullien V" first="Vincent" last="Jullien">Vincent Jullien</name><affiliation wicri:level="4"><nlm:affiliation>Service de Pharmacologie, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pharmacologie, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Redcliffe Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Redcliffe Hospital, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean-Ralph" last="Zahar">Jean-Ralph Zahar</name><affiliation wicri:level="3"><nlm:affiliation>Département de Microbiologie Clinique, Unité de Contrôle et de Prévention du risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, CHU Avicenne, 125 rue de Stalingrad, 9300, Bobigny, France. jeanralph.zahar@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de Microbiologie Clinique, Unité de Contrôle et de Prévention du risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, CHU Avicenne, 125 rue de Stalingrad, 9300, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Brun Buisson, Christian" sort="Brun Buisson, Christian" uniqKey="Brun Buisson C" first="Christian" last="Brun-Buisson">Christian Brun-Buisson</name><affiliation wicri:level="3"><nlm:affiliation>Réanimation médicale, Hôpital Henri Mondor, Université Paris Est Créteil (UPEC), Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Réanimation médicale, Hôpital Henri Mondor, Université Paris Est Créteil (UPEC), Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:29127502</idno><idno type="pmid">29127502</idno><idno type="doi">10.1186/s13613-017-0334-x</idno><idno type="wicri:Area/PubMed/Corpus">000135</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000135</idno><idno type="wicri:Area/PubMed/Curation">000135</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000135</idno><idno type="wicri:Area/PubMed/Checkpoint">000135</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000135</idno><idno type="wicri:Area/Ncbi/Merge">005199</idno><idno type="wicri:Area/Ncbi/Curation">005199</idno><idno type="wicri:Area/Ncbi/Checkpoint">005199</idno><idno type="wicri:doubleKey">2110-5820:2017:Pilmis B:piperacillin:tazobactam:as</idno><idno type="wicri:Area/Main/Merge">000600</idno><idno type="wicri:Area/Main/Curation">000605</idno><idno type="wicri:Area/Main/Exploration">000605</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Piperacillin-tazobactam as alternative to carbapenems for ICU patients.</title><author><name sortKey="Pilmis, Benoit" sort="Pilmis, Benoit" uniqKey="Pilmis B" first="Benoit" last="Pilmis">Benoit Pilmis</name><affiliation wicri:level="4"><nlm:affiliation>Service de maladies infectieuses et tropicales, Hôpital Necker Enfants malades, Service de maladies infectieuses et tropicales, Université Paris Descartes, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de maladies infectieuses et tropicales, Hôpital Necker Enfants malades, Service de maladies infectieuses et tropicales, Université Paris Descartes, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Jullien, Vincent" sort="Jullien, Vincent" uniqKey="Jullien V" first="Vincent" last="Jullien">Vincent Jullien</name><affiliation wicri:level="4"><nlm:affiliation>Service de Pharmacologie, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Pharmacologie, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Paris-Descartes</orgName></affiliation></author><author><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Redcliffe Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Redcliffe Hospital, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean-Ralph" last="Zahar">Jean-Ralph Zahar</name><affiliation wicri:level="3"><nlm:affiliation>Département de Microbiologie Clinique, Unité de Contrôle et de Prévention du risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, CHU Avicenne, 125 rue de Stalingrad, 9300, Bobigny, France. jeanralph.zahar@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de Microbiologie Clinique, Unité de Contrôle et de Prévention du risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, CHU Avicenne, 125 rue de Stalingrad, 9300, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Brun Buisson, Christian" sort="Brun Buisson, Christian" uniqKey="Brun Buisson C" first="Christian" last="Brun-Buisson">Christian Brun-Buisson</name><affiliation wicri:level="3"><nlm:affiliation>Réanimation médicale, Hôpital Henri Mondor, Université Paris Est Créteil (UPEC), Créteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Réanimation médicale, Hôpital Henri Mondor, Université Paris Est Créteil (UPEC), Créteil</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Créteil</settlement></placeName></affiliation></author></analytic><series><title level="j">Annals of intensive care</title><idno type="ISSN">2110-5820</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Several studies suggest that alternatives to carbapenems, and particulary beta-lactam/beta-lactamase inhibitor combinations, can be used for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-related infections in non-ICU patients. Little is known concerning ICU patients in whom achieving the desired plasmatic pharmacokinetic/pharmacodynamic (PK/PD) target may be difficult. Also, in vitro susceptibility to beta-lactamase inhibitors might not translate into clinical efficacy. We reviewed the recent clinical studies examining the use of BL/BLI as alternatives to carbapenems for therapy of bloodstream infection, PK/PD data and discuss potential ecological benefit from avoiding the use of carbapenems. With the lack of prospective randomized studies, treating ICU patients with ESBL-PE-related infections using piperacillin-tazobactam should be done with caution. Current data suggest that BL/BLI empirical use should be avoided for therapy of ESBL-PE-related infection. Also, definitive therapy should be reserved to patients in clinical stable condition, after microbial documentation and results of susceptibility tests. Optimization of administration and higher dosage should be used in order to reach pharmacological targets.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Bobigny</li><li>Créteil</li><li>Paris</li></settlement><orgName><li>Université Paris-Descartes</li></orgName></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Pilmis, Benoit" sort="Pilmis, Benoit" uniqKey="Pilmis B" first="Benoit" last="Pilmis">Benoit Pilmis</name></region><name sortKey="Brun Buisson, Christian" sort="Brun Buisson, Christian" uniqKey="Brun Buisson C" first="Christian" last="Brun-Buisson">Christian Brun-Buisson</name><name sortKey="Jullien, Vincent" sort="Jullien, Vincent" uniqKey="Jullien V" first="Vincent" last="Jullien">Vincent Jullien</name><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean-Ralph" last="Zahar">Jean-Ralph Zahar</name></country><country name="Australie"><noRegion><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000605 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000605 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:29127502
|texte= Piperacillin-tazobactam as alternative to carbapenems for ICU patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29127502" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |